Platelet count or bleeding as the outcome in ITP trials?
about
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.State of the art - how I manage immune thrombocytopenia.Rare complication of treated immune thrombocytopenia.Management of immune thrombocytopenia: Korean experts recommendation in 2017.Current and evolving treatment strategies in adult immune thrombocytopenia
P2860
Platelet count or bleeding as the outcome in ITP trials?
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Platelet count or bleeding as the outcome in ITP trials?
@ast
Platelet count or bleeding as the outcome in ITP trials?
@en
type
label
Platelet count or bleeding as the outcome in ITP trials?
@ast
Platelet count or bleeding as the outcome in ITP trials?
@en
prefLabel
Platelet count or bleeding as the outcome in ITP trials?
@ast
Platelet count or bleeding as the outcome in ITP trials?
@en
P2860
P356
P1476
Platelet count or bleeding as the outcome in ITP trials?
@en
P2093
Donald M Arnold
P2860
P304
P356
10.1002/AJH.23299
P577
2012-07-27T00:00:00Z